BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27529955)

  • 1. [EFFERENT THERAPY IN THE TREATMENT OF PATIENTS WITH DRUG-RESISTANT PULMONARY TUBERCULOSIS].
    Tuberk Biolezni Legkih; 2010; (3):28-33. PubMed ID: 27529955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic plasmapheresis in patients with destructive pulmonary tuberculosis].
    Karpova NL; Naumov VN; Shaĭkhaev AIa; Titiukhina MV; Sigaev AT; Enilenis II
    Probl Tuberk Bolezn Legk; 2006; (6):14-7. PubMed ID: 16881228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience with small-volume plasmapheresis used in the correction of hemostatic disorders in patients with progressive destructive pulmonary tuberculosis].
    Karpina NL; Kaminskaia GO; Serebrianaia BA; Erokhin VV
    Probl Tuberk Bolezn Legk; 2007; (11):33-7. PubMed ID: 18080532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correction of bronchial obstructive syndrome and antituberculous drugs-induced eosinophilia in patients with pulmonary tuberculosis by using plasmapheresis].
    Shmelev EI; Stepanian IE
    Probl Tuberk; 1996; (6):57-60. PubMed ID: 9019774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of artificial pneumothorax in the treatment of patients with pulmonary tuberculosis with multiple drug-resistant Mycobacteria].
    Chukanov VI; Mishin VIu; Sigaev AT; Vasil'eva IA; Osadchaia OA; Perfil'ev AV; Naumova AN; Bagdasarian TR
    Probl Tuberk Bolezn Legk; 2004; (8):22-4. PubMed ID: 15478553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retrosternal lymphotropic chemotherapy and pneumoperitoneum in the treatment of drug-resistant destructive pulmonary tuberculosis].
    Kibrik BS; Zakharov AV; Lobanovskiĭ VM
    Probl Tuberk Bolezn Legk; 2009; (5):21-6. PubMed ID: 19565808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CLINICAL AND X-RAY CHANGES IN PATIENTS WITH NEW-ONSET MULTIDRUG-RESISTANT MYCOBACTERIUM PULMONARY TUBERCULOSIS IN THE EARLY USE OF A RESERVE CHEMOTHERAPY REGIMEN ACCORDING TO THE TB-BIOCHIP TEST SYSTEM DATA].
    Tuberk Biolezni Legkih; 2010; (4):10-3. PubMed ID: 27534019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].
    Gubkina MF; Ershova NG
    Probl Tuberk Bolezn Legk; 2009; (1):33-6. PubMed ID: 19256010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [SURGICAL TREATMENT FOR DESTRUCTIVE PULMONARY TUBERCULOSIS IN FIRST DETECTED PATIENTS].
    Tuberk Biolezni Legkih; 2010; (6):57-63. PubMed ID: 27534058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of successful use of valvular bronchial blockage in the complex treatment of a patient with multidrug fibrocavernous pulmonary tuberculosis].
    Levin AV; Tseĭmakh EA; Zimonin PE; Samuĭlenkov AM; Nikolaeva OB; Evdokimov SN
    Probl Tuberk Bolezn Legk; 2008; (3):35-8. PubMed ID: 18453055
    [No Abstract]   [Full Text] [Related]  

  • 13. A subset of clinical status of pulmonary tuberculosis in Southern Taiwan.
    Tsai MS; Chong IW; Hwang JJ; Wang TH; Huang MS
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):136-9. PubMed ID: 15272756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of multidrug-resistant tuberculosis].
    Yagi T; Yamagishi F; Sasaki Y; Hamaoka T; Kuroda F; Higurashi H
    Kekkaku; 2001 Dec; 76(12):717-21. PubMed ID: 11806127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [IMMEDIATE RESULTS OF SURGICAL TREATMENT IN DESTRUCTIVE PULMONARY TUBERCULOSIS PATIENTS EXCRETING EXTREME DRUG-RESISTANT MBT].
    Tuberk Biolezni Legkih; 2010; (3):18-22. PubMed ID: 27529953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasmapheresis in the complex treatment of patients with acutely progressive pulmonary tuberculosis].
    Makieva VG; Polosukhin SM; Dryga OP; Mishin VIu
    Probl Tuberk; 2002; (12):26-9. PubMed ID: 12611331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ways of overcoming drug resistance in patients with pulmonary tuberculosis].
    Grishin MN; Svistov VV; Krivoshein IuS
    Probl Tuberk; 2002; (3):16-8. PubMed ID: 12066525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of surfactant-BL on ventilation and gas exchange function in patients with destructive pulmonary tuberculosis].
    Chernichenko NV; Shergina EA; Lovacheva OV; Erokhin VV
    Probl Tuberk Bolezn Legk; 2006; (6):6-10. PubMed ID: 16881226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.